These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 30827998

  • 1. Potential Anticancer Activity of Auranofin.
    Onodera T, Momose I, Kawada M.
    Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
    [Abstract] [Full Text] [Related]

  • 2. [Potential Anticancer Activity of Auranofin].
    Momose I, Onodera T, Kawada M.
    Yakugaku Zasshi; 2021; 141(3):315-321. PubMed ID: 33642497
    [Abstract] [Full Text] [Related]

  • 3. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J, Li X, Han X, Liu R, Fang J.
    Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
    Liu JJ, Liu Q, Wei HL, Yi J, Zhao HS, Gao LP.
    Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084
    [Abstract] [Full Text] [Related]

  • 5. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV, Di Trapani G, Vuckovic S, Tonissen KF.
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [Abstract] [Full Text] [Related]

  • 6. Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-hydroxynonenal.
    Zhang H, Du Y, Zhang X, Lu J, Holmgren A.
    Antioxid Redox Signal; 2014 Aug 10; 21(5):669-81. PubMed ID: 24295294
    [Abstract] [Full Text] [Related]

  • 7. The thioredoxin system and cancer therapy: a review.
    Mohammadi F, Soltani A, Ghahremanloo A, Javid H, Hashemy SI.
    Cancer Chemother Pharmacol; 2019 Nov 10; 84(5):925-935. PubMed ID: 31367788
    [Abstract] [Full Text] [Related]

  • 8. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S, Cebula M, Pader I, Arnér ES.
    Free Radic Biol Med; 2010 Dec 01; 49(11):1765-78. PubMed ID: 20851179
    [Abstract] [Full Text] [Related]

  • 9. Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload.
    Harper MT.
    Platelets; 2019 Dec 01; 30(1):98-104. PubMed ID: 29194002
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
    Liu C, Liu Z, Li M, Li X, Wong YS, Ngai SM, Zheng W, Zhang Y, Chen T.
    PLoS One; 2013 Dec 01; 8(1):e53945. PubMed ID: 23342042
    [Abstract] [Full Text] [Related]

  • 11. X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action.
    Parsonage D, Sheng F, Hirata K, Debnath A, McKerrow JH, Reed SL, Abagyan R, Poole LB, Podust LM.
    J Struct Biol; 2016 May 01; 194(2):180-90. PubMed ID: 26876147
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
    Zhang J, Yao J, Peng S, Li X, Fang J.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan 01; 1863(1):129-138. PubMed ID: 27777067
    [Abstract] [Full Text] [Related]

  • 14. Sugar-Modified Analogs of Auranofin Are Potent Inhibitors of the Gastric Pathogen Helicobacter pylori.
    Epstein TD, Wu B, Moulton KD, Yan M, Dube DH.
    ACS Infect Dis; 2019 Oct 11; 5(10):1682-1687. PubMed ID: 31487153
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF, Di Trapani G.
    Mol Nutr Food Res; 2009 Jan 11; 53(1):87-103. PubMed ID: 18979503
    [Abstract] [Full Text] [Related]

  • 17. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
    Zhang X, Selvaraju K, Saei AA, D'Arcy P, Zubarev RA, Arnér ES, Linder S.
    Biochimie; 2019 Jul 11; 162():46-54. PubMed ID: 30946948
    [Abstract] [Full Text] [Related]

  • 18. Thioredoxin-mimetic peptides (TXM) reverse auranofin induced apoptosis and restore insulin secretion in insulinoma cells.
    Cohen-Kutner M, Khomsky L, Trus M, Aisner Y, Niv MY, Benhar M, Atlas D.
    Biochem Pharmacol; 2013 Apr 01; 85(7):977-90. PubMed ID: 23327993
    [Abstract] [Full Text] [Related]

  • 19. Protection of CDC25 phosphatases against oxidative stress in breast cancer cells: evaluation of the implication of the thioredoxin system.
    Beillerot A, Battaglia E, Bennasroune A, Bagrel D.
    Free Radic Res; 2012 May 01; 46(5):674-89. PubMed ID: 22360685
    [Abstract] [Full Text] [Related]

  • 20. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
    Schuh E, Pflüger C, Citta A, Folda A, Rigobello MP, Bindoli A, Casini A, Mohr F.
    J Med Chem; 2012 Jun 14; 55(11):5518-28. PubMed ID: 22621714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.